Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?

Punnen S, Cooperberg MR, Sadetsky N, Carroll PR.

BJU Int. 2012 May;109(10):1520-4. doi: 10.1111/j.1464-410X.2011.10605.x. Epub 2011 Oct 14.

2.

Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother.

Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD.

BJU Int. 2012 May;109(9):1366-74. doi: 10.1111/j.1464-410X.2011.10598.x. Epub 2011 Oct 14.

3.

Changes in specific domains of sexual function and sexual bother after radical prostatectomy.

Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR; CaPSURE Investigators.

BJU Int. 2010 Oct;106(7):1022-9. doi: 10.1111/j.1464-410X.2010.09231.x. Epub 2010 Feb 23.

4.

Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.

Kimura M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, Donatucci CF, Moul JW.

Andrology. 2013 Mar;1(2):256-61. doi: 10.1111/j.2047-2927.2012.00036.x. Epub 2012 Nov 29.

5.

Sexual bother following radical prostatectomyjsm.

Nelson CJ, Deveci S, Stasi J, Scardino PT, Mulhall JP.

J Sex Med. 2010 Jan;7(1 Pt 1):129-35.

PMID:
20104671
6.

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE.

Urology. 2003 Jan;61(1):190-6.

7.

The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.

Lee IH, Sadetsky N, Carroll PR, Sandler HM.

J Urol. 2008 Mar;179(3):1072-6; discussion 1076. doi: 10.1016/j.juro.2007.10.053. Epub 2008 Jan 18.

PMID:
18206926
8.

Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy.

Harris CR, Punnen S, Carroll PR.

J Urol. 2013 Sep;190(3):981-6. doi: 10.1016/j.juro.2013.02.008. Epub 2013 Feb 11.

PMID:
23410984
9.

Dissociation between patients and their partners in expectations for sexual life after radical prostatectomy.

Sato Y, Tanda H, Nakajima H, Nitta T, Akagashi K, Hanzawa T, Tobe M, Haga K, Uchida K, Honma I.

Int J Urol. 2013 Mar;20(3):322-8. doi: 10.1111/iju.12022. Epub 2013 Jan 8.

11.

Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy.

Kimura M, Caso JR, Bañez LL, Koontz BF, Gerber L, Senocak C, Donatucci CF, Vujaskovic Z, Moul JW, Polascik TJ.

BJU Int. 2012 Dec;110(11 Pt C):E931-8. doi: 10.1111/j.1464-410X.2012.11168.x. Epub 2012 Apr 23.

12.

Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.

Sridhar AN, Cathcart PJ, Yap T, Hines J, Nathan S, Briggs TP, Kelly JD, Minhas S.

J Sex Med. 2016 Mar;13(3):435-43. doi: 10.1016/j.jsxm.2016.01.005.

PMID:
26944466
13.

Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.

Kuwata Y, Muneuchi G, Igawa HH, Tsukuda F, Inui M, Kakehi Y.

Int J Urol. 2007 Jun;14(6):510-4.

14.

Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer.

Gacci M, Corona G, Apolone G, Lanciotti M, Tosi N, Giancane S, Masieri L, Serni S, Maggi M, Carini M.

Prostate Cancer Prostatic Dis. 2010 Jun;13(2):168-72. doi: 10.1038/pcan.2010.4. Epub 2010 Mar 9. Erratum in: Prostate Cancer Prostatic Dis. 2010 Jun;13(2):202. Apolone, A [corrected to Apolone, G].

15.

Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.

Gacci M, Simonato A, Masieri L, Gore JL, Lanciotti M, Mantella A, Rossetti MA, Serni S, Varca V, Romagnoli A, Ambruosi C, Venzano F, Esposito M, Montanaro T, Carmignani G, Carini M.

Health Qual Life Outcomes. 2009 Nov 13;7:94. doi: 10.1186/1477-7525-7-94.

16.

The effect of erectile function on the use of phosphodiesterase-5 inhibitors after radical prostatectomy in Japanese and U.S. men.

Namiki S, Kwan L, Kagawa-Singer M, Arai Y, Litwin MS.

Urology. 2008 May;71(5):901-5. doi: 10.1016/j.urology.2007.12.033. Epub 2008 Mar 28.

PMID:
18374396
17.

Is laparoscopic unilateral sural nerve grafting during radical prostatectomy effective in retaining sexual potency?

Porpiglia F, Ragni F, Terrone C, Renard J, Musso F, Grande S, Cracco C, Ghignone G, Scarpa RM.

BJU Int. 2005 Jun;95(9):1267-71.

18.

Chronology of erectile function in patients with early functional erections following radical prostatectomy.

Katz D, Bennett NE, Stasi J, Eastham JA, Guillonneau BD, Scardino PT, Mulhall JP.

J Sex Med. 2010 Feb;7(2 Pt 1):803-9. doi: 10.1111/j.1743-6109.2009.01516.x. Epub 2009 Sep 30.

PMID:
19796019
19.

Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.

Basal S, Wambi C, Acikel C, Gupta M, Badani K.

BJU Int. 2013 Apr;111(4):658-65. doi: 10.1111/j.1464-410X.2012.11487.x. Epub 2012 Nov 27.

20.

Life after radical prostatectomy: a longitudinal study.

Litwin MS, Melmed GY, Nakazon T.

J Urol. 2001 Aug;166(2):587-92.

PMID:
11458073

Supplemental Content

Support Center